Yurko-Mauro K, Alexander DD, Van Elswyk ME
Book a consultation today to see whether GLP-1 therapy fits your weight management goals
as of mid-2026 it has only been nominated (not approved) for FDA 503A bulk-compounding review
These drugs are administered via injectables, with some oral variants in development
SIRT3 suppression resulting from the enhanced -catenin signaling drives glycolysis and promotes hypoxia-induced cell growth in hepatocellular carcinoma cells
Pay close attention to: Inclusion and exclusion criteria Location (some trials require in-person visits) Frequency of check ins Study design, like whether the study is randomized and placebo-controlled (a placebo-controlled trial means not everyone receives the medication, which is an important consideration) Study duration (if youre in the placebo group, this is how long without treatment, too!) For instance, some retatrutide clinical trials are only enrolling people with obesity, which means you must be above a certain BMI to qualify